🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Molbio Diagnostics posts Rs 1,020 Cr revenue, Rs 138 Cr PAT in FY25

EntrackrEntrackr · 1m ago
Molbio Diagnostics posts Rs 1,020 Cr revenue, Rs 138 Cr PAT in FY25
Medial

Goa-based molecular diagnostics firm Molbio closed FY25 with Rs 1,020 crore in revenue and Rs 138.5 crore profit, marking a sharp recovery from its post-COVID slump. The Temasek-backed unicorn, which had shot into the limelight during the pandemic, saw its revenue peak at Rs 1,272 crore in FY21 before crashing to Rs 332 crore in FY23. According to its draft red herring prospectus (DRHP) filed with SEBI, Molbio’s scale grew 22% from Rs 836 crore in FY24 while its profits surged 66% during FY25, underlining the company’s turnaround ahead of its proposed public listing. The growth was largely powered by its flagship Truenat platform, a portable, battery-operated molecular testing system used for tuberculosis and over 30 other infectious diseases. As per the DRHP, the company claims to have sold 2,180 devices with 12.24 million test kits in FY25. Molbio’s total expenses grew 25% to Rs 820 crore in FY25. Raw material consumption accounted for more than half of the cost base at Rs 413 crore, while employee benefits rose 61% to Rs 103 crore. Advertising and marketing spend nearly doubled to Rs 22 crore. At the same time, the company’s EBITDA margin stood at 26.17% while return on capital employed (ROCE) was at 22.06% in FY25. On a unit level, it spent Rs 0.80 to earn a rupee of revenue, compared to Rs 0.82 in FY24. The company currently operates five manufacturing units across Goa, Bengaluru, and Visakhapatnam, with an installed capacity of 3,600 Truenat devices and 3.9 crore test kits annually. Backed by Temasek and Motilal Oswal Private Equity, Molbio has raised about Rs 970 crore to date. Through its IPO, Molbio plans to raise Rs 200 crore via a fresh issue, while existing shareholders will offload 1.25 crore shares through an offer for sale. The proceeds will be used for a new R&D facility, expansion of manufacturing units, and general corporate purposes. As per the DRHP, Exxora Trading LLP is the largest shareholder in Molbio with a 41.23% stake, followed by India Business Excellence Fund at 12.66%. Temasek owns 8.93%, while Gopalkrishna Mangalore Kini and Dr. Chandrasekhar Bhaskaran Nair hold 6.73% and 5.42%, respectively. Molbio has bounced back from its pandemic boom and later slump to steady growth and profits, making it one of the few healthcare startups ready to go public. Its IPO will be watched closely to gauge investor interest in diagnostics companies after COVID-19.

Related News

Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses

EntrackrEntrackr · 3m ago
Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses
Medial

Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses Diagnostics platform Redcliffe Labs has posted a 20% increase in its operating revenue to Rs 419 crore in FY25 from Rs 350 crore in FY24 and managed to narrow its EBITDA losses, as per the company’s press release. Diagnostics platform Redcliffe Labs has posted a 20% increase in its operating revenue to Rs 419 crore in FY25 from Rs 350 crore in FY24, as per the company’s press release. The Gurugram-based firm also managed to reduce its EBITDA losses from -38% to -21% during the same period. Founded by Aditya Kandoi, Redcliffe operates a nationwide network of over 80 labs and claims to have the widest home sample collection footprint in the country. Diagnostic services contributed over 95% of the company’s revenue in FY25, with the rest coming from product sales and other operating income. The company said it diagnosed over 2.5 million cases last fiscal and continues to focus on expanding in underserved regions, with more than 70% of its testing volumes now coming from Tier II cities and beyond. On the profitability front, Redcliffe reported a gross margin of 70% in FY25 and is aiming to expand it to 74% in FY26. It has also set a revenue target of Rs 560 crore for the ongoing fiscal through organic growth and strategic acquisitions. “We are transforming lives and making diagnostics a first-line solution for millions who were previously underserved,” said Kandoi. The company plans to expand its presence to over 300 cities with 150 labs by FY28. According to startup data platform TheKredible, Redcliffe has raised $113 million to date, including a $42 million Series C round led by LeapFrog. It also acquired Bengaluru-based Celara Diagnostics in a $7 million deal. Redcliffe competes with players like PharmEasy-owned Thyrocare, Tata 1mg, and Healthians.

After Rs 215 Cr profit in FY22, Molbio reports Rs 3 Cr loss in FY23

EntrackrEntrackr · 1y ago
After Rs 215 Cr profit in FY22, Molbio reports Rs 3 Cr loss in FY23
Medial

Healthcare diagnostics firm Molbio achieved unicorn status after a $85 million funding round led by Temasek in September 2022, but its success was short-lived, lasting only through the pandemic. Molbio’s revenue plummeted 74%, from Rs 1,272 crore in FY21 to Rs 332 crore in FY23. Significantly, the company slipped into losses in FY23 and posted a loss of Rs 3.4 crore in the same period as compared to Rs 215 cr profit in FY22. On a year-on-year basis, the firm, also the first ever Unicorn from Goa saw a 57% decline in its revenue to Rs 332 crore in FY23 from Rs 776 crore in FY22, its annual financial statement sourced from the RoC shows. Truenat, the flagship product of Molbio Diagnostics, provides a real-time IoT-enabled testing kit for over 30 diseases. The sale of Truenat, Micro PCR workstations, reagent kits, and cartridges were some major avenues for the company’s collections. Truenat is mostly relevant for the diagnosis of Tuberculosis. The Goa-based firm also made Rs 5 crore from interest and gain on financial assets tallying its overall revenue to Rs 337 crore in FY23. For the diagnostic firm, the cost procurement of raw materials and medical components accounted for 44% of the overall expenditure. In the line with the scale, this cost decreased by 47.4% to Rs 143 crore in FY23. Molbio’s spending on employee benefits, traveling, legal, advertising cum promotional, freight, and other overheads took the overall cost to Rs 328 crore in FY23 from Rs 486 crore in FY22. The 57% decline in scale and the pressure of fixed costs pushed Molbio into the red and it reported a loss of Rs 3.4 crore in FY23. This is a significant downturn compared to the Rs 215 crore profit posted by the firm in FY22. Its ROCE and EBITDA margin worsened to 2% and 14.5%, respectively. On a unit level, it spent Rs 0.99 to earn a rupee in FY23. The Goa-based company has raised Rs 970 crore to date. According to the startup data intelligence platform TheKredible, its promoters through Exxora Trading LLP are the largest stakeholders with 41.7% shares followed by Motilal Oswal which commands 12.96%. Molbio claims that it closed FY24 with Rs 850 crore in revenue and has plans to strengthen its global presence this fiscal, along with launching new products in the Indian market. With these initiatives, it targets a revenue of Rs 1,200 crore and plans to raise around Rs 2,200 crore to Rs 2,400 crore via public listing in the ongoing fiscal year (FY25). FY23-FY24 FY23 FY24 EBITDA Margin 48% 14.5% Expense/₹ of Op Revenue ₹0.63 ₹0.99 ROCE 44% 2% Large fundraising plans along with growth ambitions are par for the course for a firm that has taken the kind of hits Molbio has. It might not find it as simple to convince investors it can execute, especially in a market where both regulations and perceptions towards portable testing kits are changing, even as Truenat itself remains relevant thanks to the wide prevalence of tuberculosis and its variations even today. Cost pressures from other, more low cost options is just one side of the market, even as its own plans to expand to other disease diagnostics need to show real progress fast.

Nazara posts Rs 520 Cr revenue and Rs 4 Cr PAT in Q4 FY25

EntrackrEntrackr · 4m ago
Nazara posts Rs 520 Cr revenue and Rs 4 Cr PAT in Q4 FY25
Medial

Nazara posts Rs 520 Cr revenue and Rs 4 Cr PAT in Q4 FY25 Gaming and sports media firm Nazara Technologies reported a 95% year-on-year rise in operating revenue for Q4 FY25. However, the Mumbai-based company’s profit remained modest at Rs 4 crore in the final quarter of the previous fiscal year. Nazara’s operating revenue rose by 95.3% to Rs 520 crore in Q4 FY25 from Rs 266 crore in Q4 FY24, according to its audited consolidated financial statements sourced from the National Stock Exchange (NSE). E-sports accounted for 41.5% (Rs 216 crore) of the company’s total operating revenue, while the gaming segment held a 30% share (Rs 156 crore), followed by ad tech, which contributed 28% (Rs 148 crore). Nazara also earned Rs 18 crore from interest and gains on financial assets during the quarter, bringing its overall revenue to Rs 539 crore. However, the company posted a 40.8% YoY increase in its total income to Rs 1,715 crore in FY25, compared to Rs 1,218 crore in FY24. On the line of scale, Nazara’s total expenses surged by 85.3% to Rs 528 crore in Q4 FY25, compared to Rs 285 crore in the same quarter last year. Content and commission costs together stood at Rs 186 crore, while employee benefit expenses rose to Rs 80 crore. Notably, marketing expenses saw a sharp 3.5X jump, reaching Rs 151 crore in Q4 FY25. Despite a 95% year-on-year revenue growth in Q4, the company’s profit remained flat at Rs 4 crore in Q4 FY25. For the full fiscal year, its net profit declined to Rs 51 crore in FY25 from Rs 74.7 crore in FY24. Last week, the Competition Commission of India (CCI) also approved the acquisition of a majority stake and control over Nazara Technologies Limited by Axana Estates LLP, Plutus Wealth Management LLP, and Junomoneta Finsol Private Limited. Nazara is currently trading at Rs 1,270 (as of 03.41 PM) with a total market capitalization of Rs 11,127 crore (approximately $1.3 billion).

TBO Tek posts Rs 446 Cr revenue and Rs 59 Cr PAT in Q4 FY25

EntrackrEntrackr · 5m ago
TBO Tek posts Rs 446 Cr revenue and Rs 59 Cr PAT in Q4 FY25
Medial

Business-focused travel distribution platform Travel Boutique Online (TBO) has recorded a 21% year-on-year increase in its revenue while its profits grew 28.3% during the fourth quarter of the last fiscal year (FY25). TBO’s operating revenue increased to Rs 446 crore in Q4 FY25 from Rs 369 crore in Q3 FY24, its consolidated financial statements sourced from the National Stock Exchange (NSE) show. Income from the booking of hotels and packages accounted for 80% of TBO’s revenue, which increased to Rs 357 crore in Q4 FY25. Meanwhile, income from air ticketing and other allied services brought Rs 79 crore and Rs 10 crore to the firm’s coffers. Hotels and packages, as the top revenue source, made service fees the largest cost center, accounting for 33.75% of total expenditure or Rs 135 crore in Q4 FY25. Employee benefits were Rs 99 crore in the same quarter. Overall, total costs rose to Rs 400 crore in Q4 FY25 from Rs 325 crore in Q4 FY24. The decent surge in scale and controlled expenditure led TBO to post a 28.3% YOY increase in its profits after tax to Rs 59 crore in Q4 FY25 from Rs 46 crore in Q4 FY24. However, for the full fiscal year, it posted a 15% YoY increase in PAT to Rs 230 crore in the previous fiscal (FY25). At the end of today’s (Thursday, May 22) trading session, TBO Tek saw around a 3% decrease in its stock, which stood at Rs 1,197 with a total market capitalization of Rs 13,005 crore or ($1.53 billion).

Auxilo reports Rs 528 Cr revenue and Rs 112 Cr PAT in FY25

EntrackrEntrackr · 26d ago
Auxilo reports Rs 528 Cr revenue and Rs 112 Cr PAT in FY25
Medial

Auxilo reports Rs 528 Cr revenue and Rs 112 Cr PAT in FY25 Auxilo’s revenue from operations grew 48.3% to Rs 528 crore in FY25, up from Rs 356 crore in FY24, as per its annual financial statements sourced from the Registrar of Companies. After doubling its revenue in FY24, education-focused non-banking financial company (NBFC) Auxilo has delivered another strong performance in FY25, going past Rs 500 crore in revenue and posting over Rs 100 crore in profit after tax (PAT). The Mumbai-based NBFC provides education loans to students pursuing higher studies in India and abroad. Its offerings cover the complete cost of education, including tuition fees, pre-visa expenses, travel, and other related costs. Interest income formed the bulk of its business, contributing 90.5% of total operating revenue, which grew 49.4% to Rs 478 crore in FY25. Fees, commissions, and other operating income collectively stood at Rs 50 crore during the year. Including other income of Rs 16 crore, Auxilo’s total revenue reached Rs 544 crore in FY25. On the expenditure side, interest costs accounted for 71.5% of total expenses, rising in line with disbursements to Rs 282 crore in FY25. Employee benefits were recorded at Rs 56 crore, while overall costs increased to Rs 394 crore in FY25, compared to Rs 275 crore in FY24. The company’s controlled cost structure supported profitability, leading to a 62.3% jump in PAT to Rs 112 crore in FY25, against Rs 69 crore in FY24. Auxilo’s expense-to-revenue ratio also improved to 0.75 in FY25. Earlier this year, Auxilo raised Rs 50 crore from Motilal Oswal. Since its inception, it has secured over $100 million across equity and debt. The company competes with other well-funded education-financing players such as Grayquest, Avanse Financial, Financepeer, Propelld, Leap Finance, and Eduvanz.

Milky Mist posts Rs 2,349 Cr revenue in FY25, profit jumps over 2.4X

EntrackrEntrackr · 3m ago
Milky Mist posts Rs 2,349 Cr revenue in FY25, profit jumps over 2.4X
Medial

Milky Mist posts Rs 2,349 Cr revenue in FY25, profit jumps over 2.4X Dairy company Milky Mist has filed its draft red herring prospectus (DRHP) with the Securities Exchange Board of India to raise up to Rs 2,035 crore through an initial public offering (IPO). The company's financial report for FY25 indicates a 2.4X spike in its profit with a decent growth in revenue. Milky Mist’s revenue from operations grew 29% to Rs 2,349 crore in FY25 from Rs 1,822 crore in FY24, according to its restated financial statement sourced from the DRHP. Paneer remained Milky Mist’s top-selling product in FY25 with Rs 694 crore in revenue, followed by cheese at Rs 408 crore and curd at Rs 370 crore. Ice cream emerged as the fastest-growing segment with a 294% jump to Rs 138 crore, while other products like ghee, milk, and beverages brought in Rs 739.5 crore. Regionally, Karnataka and Tamil Nadu led the charts with nearly equal contributions, while West India (Rs 418 crore) and North-Central India (Rs 116 crore) posted the highest growth at 49% and 55%, respectively. Export revenue also surged 43% to Rs 88.5 crore. On the expense front, the cost of materials continued to be the biggest outlay, growing 24% to Rs 1,553 crore in FY25. Employee benefit expenses rose to Rs 145 crore, while depreciation and finance costs increased to Rs 136 crore and Rs 86 crore, respectively. Notably, selling and distribution costs jumped over 134% to Rs 122 crore. Overall, total expenses increased 27% to Rs 2,267 crore in FY25 from Rs 1,784 crore a year earlier. Milky Mist ended the year with a return to strong profitability, with a spike of 2.4X to Rs 46 crore in FY25 from Rs 19 crore in FY24. Its ROCE and EBITDA margin stood at 11.57% and 13.14% respectively. The company spent Rs 0.96 to earn a rupee of operating revenue in FY25. The company reported current assets worth Rs 419 crore, including Rs 21 crore in cash and bank balance. As per the DRHP, Anitha S is the largest shareholder with a 51.45% stake in Milky Mist, followed by T. Sathishkumar who owns 40.94%. Aquarius Family Private Trust and Taurus Family Private Trust hold 2.5% each in the company. JM Financial, Axis Capital, and IIFL Securities are the book-running lead managers for the IPO.

Garuda Aerospace posts Rs 17.5 Cr profit in FY25, revenue at Rs 118 Cr

EntrackrEntrackr · 2m ago
Garuda Aerospace posts Rs 17.5 Cr profit in FY25, revenue at Rs 118 Cr
Medial

Garuda Aerospace posts Rs 17.5 Cr profit in FY25, revenue at Rs 118 Cr Drone technology startup Garuda Aerospace reported a modest growth in the last financial year ending March 31, 2025. The Bengaluru-based firm maintained profitability, supported by steady revenue growth and cost discipline. Garuda’s revenue from operations increased 7.3% to Rs 118 crore in FY25 from Rs 110 crore in FY24, as per its unaudited financial statements filed with the Registrar of Companies (RoC). Garuda Aerospace designs, manufactures and customizes Unmanned Aerial Vehicle (UAVs or drones) for various use cases such as deliveries, disaster management and agriculture. The company made additional Rs 7 crore from other income, which increased its total income to Rs 125 crore in FY25, from Rs 111 crore in FY24. Looking at the expenses, the cost of materials, which formed the largest expense, rose 14% to Rs 56 crore in FY25 from Rs 49 crore a year ago. Employee benefit expenses declined 12% to Rs 9.23 crore, while finance costs halved to Rs 1 crore during the same period. Depreciation, however, increased to Rs 3 crore in FY25 from Rs 2 crore in FY24. Overall, Garuda’s total expenses grew 13% to Rs 100.5 crore in FY25 as against Rs 89 crore in FY24. Despite higher spending, the company managed to expand its bottom line, with profit after tax (PAT) rising 9.4% to Rs 17.5 crore in FY25, from Rs 16 crore in FY24. Its ROCE and EBITDA margin stood at 14.37% and 22.4% respectively. On a unit level, Garuda spent Rs 0.85 to earn a rupee of revenue during the fiscal year. The company recorded current assets worth Rs 179 crore. According to startup data intelligence platform TheKredible, Garuda Aerospace has raised approximately $44 million to date from investors such as Nagarajan Seyyadurai, Ocgrow Ventures, cricketer MS Dhoni and others. Garuda operates a fleet of 400 drones and 500 pilots across 84 cities. The company recently raised funds from Narotam Sekhsaria Family Office to scale up manufacturing capacity from the current 8,000 drones annually to between 12,000 and 15,000 units. It will also expand its export presence to 50 countries by the year-end.

MamaEarth-parent Honasa posts Rs 595 Cr revenue in Q1 FY26; PAT grows 2.7%

EntrackrEntrackr · 2m ago
MamaEarth-parent Honasa posts Rs 595 Cr revenue in Q1 FY26; PAT grows 2.7%
Medial

### MamaEarth-parent Honasa Posts Rs 595 Cr Revenue in Q1 FY26; PAT Grows 2.7% MamaEarth’s revenue from operations increased by 7.4% YoY to Rs 595 crore in Q1 FY26 from Rs 554 crore in Q1 FY25, its financial statements accessed from the National Stock Exchange (NSE) show. Honasa Consumer Limited, the parent company of personal care brand Mamaearth, has announced its financial results for the first quarter of the ongoing fiscal year (Q1 FY26). The Gurugram-based company reported a 7% growth in scale, while its year-on-year (YoY) profits increased by 2.7% during the same period. MamaEarth’s operating revenue increased 12% to Rs 595 crore in Q1 FY26 from Rs 533 crore in Q4 FY25. The company added Rs 24 crore from non-operating activities which tallied its overall revenue to Rs 619 crore in Q1 FY26. For the D2C brand, the cost of procurement of products accounted for 30% of the overall expenditure. This cost increased by 9% to Rs 171 crore in Q1 FY26 from Rs 157 crore in Q1 FY25. The company’s spending on employee benefits, marketing, legal, rent, and other overheads drove an 8% year-on-year rise in total expenditure to Rs 563 crore in Q1 FY26 from Rs 520 crore in Q1 FY25. The company reported a profit after tax of Rs 41.3 crore in Q1 FY26, 5% up from Rs 40.2 crore in Q1 FY25. On a unit basis, the company spent Re 0.95 to earn a Rupee of operating revenue with EBITDA of Rs 55 in Q1 FY26. MamaEarth parent’s shares were trading at Rs 271 with a total marketing capitalization of Rs 8,812 crore ($1 billion).

Paytm posts Rs 1,828 Cr revenue and Rs 208 Cr loss in Q3 FY25

EntrackrEntrackr · 9m ago
Paytm posts Rs 1,828 Cr revenue and Rs 208 Cr loss in Q3 FY25
Medial

Fintech firm Paytm announced its financial results for the third quarter of the current fiscal year (Q3 FY25) on Monday. The Noida-based company reported revenue of Rs 1,828 crore and a net loss of Rs 208 crore for the period. According to Paytm’s unaudited consolidated quarterly report filed with the National Stock Exchange, its revenue from operations declined by 35.9% year-on-year from Rs 2,850 crore in Q3 FY24 to Rs 1,828 crore in Q3 FY25. However, on a quarter-on-quarter basis, the firm recorded a 10% increase in revenue compared to Q2 FY25 (the preceding quarter). Income from payment service revenue accounted for 55% of the total operating revenue which stood at Rs 1,003 crore in Q3 FY25 while the revenue from financial and marketing services were recorded at Rs 502 crore and Rs 267 crore in the same period. The company also added Rs 189 crore from other non-operating sources, bringing its overall revenue to Rs 2016.5 crore in Q3 FY25. For the fintech firm, its employee benefits remained the largest cost center accounting for 34% of the overall cost which decreased by 36% to Rs 756 crore in Q3 FY25. This includes Rs 182 crore as ESOP cost (non-cash). Its payment processing charges and marketing costs were reduced by 42% and 48.7% to Rs 570 crore and Rs 141 crore respectively in Q3 FY25 from Rs 982 crore and Rs 275 crore in Q3 FY24. Software, communication, legal, cashback, and other overheads took the total expenditure to Rs 2,220 crore in Q3 FY25 from Rs 3,216 crore in Q3 FY24. A reduction across all overhead departments enabled Paytm to narrow its losses by 6.3% to Rs 208 crore in Q3 FY25 from Rs 222 crore in Q3 FY24.

MapMyIndia posts Rs 140 Cr revenue in Q4 FY25, profit grows 29%

EntrackrEntrackr · 5m ago
MapMyIndia posts Rs 140 Cr revenue in Q4 FY25, profit grows 29%
Medial

MapMyIndia posts Rs 140 Cr revenue in Q4 FY25, profit grows 29% CE Info Systems, the parent company of MapMyIndia, has announced its financial results for the fourth quarter of FY25. The company reported a year-on-year revenue growth of over 34% compared to Q4 FY24. MapMyIndia’s revenue from operations increased to Rs 143 crore in Q4 FY25 from Rs 107 crore in Q4 FY24. Meanwhile, for the full fiscal year, revenue increased by 22% to Rs 463 crore in FY25 from Rs 379 crore in FY24, according to its consolidated quarterly report. Income from digital map data, GPS navigation, location-based services, and IoT was the primary source of revenue for MapMyIndia, accounting for 88% of the total collection. This revenue source increased by 51% to Rs 127 crore in Q4 FY25. However, income from the sale of its devices generated Rs 16.5 crore in revenue. The cost of IoT devices, employee benefits, and outsourced technical services were the major cost elements, pushing the total cost of the firm to Rs 90 crore in Q4 FY25, up from Rs 72 crore in Q4 FY24. On a fiscal basis, the total cost increased to Rs 306 crore in FY25. With the increase in scale, MapMyIndia recorded a 29% increase in its profit to Rs 49 crore during Q4 FY25, compared to Rs 38 crore in the fourth quarter of the previous fiscal year. Meanwhile, annual profit increased by 10% to Rs 148 crore in FY25, up from Rs 134 crore in FY24. At the end of the day on 9th May 2025, MapMyIndia closed at Rs 1,845 per share, with a market capitalization of Rs 10,040 crore ($1.17 billion).

Download the medial app to read full posts, comements and news.